FINCH THERAPEUTICS
Finch Therapeutics is a mission-driven microbiome engineering company, is developing novel microbial therapies to serve patients with serious and unmet medical needs. The company uses machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. This human-centric discovery model leverages clinical data to focus on in-vitro and in-vivo efforts on cocktails of microbes that have already demonstrated safety and efficacy in humans. This enables early retirement of translational risk and avoids the challenges of extrapolating host-specific effects from animal models. Finch Therapeutics was founded in 2017 and is headquartered in Somerville, Massachusetts.
FINCH THERAPEUTICS
Industry:
Biotechnology Clinical Trials Machine Learning Therapeutics
Founded:
2017-01-01
Address:
Somerville, Massachusetts, United States
Country:
United States
Website Url:
http://www.finchtherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
(617) 229-6499
Email Addresses:
[email protected]
Total Funding:
188.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-10-23 | Crestovo | Crestovo acquired by Finch Therapeutics | N/A |
Investors List
Symbiosis Group
Symbiosis Group investment in Series D - Finch Therapeutics
Willett Advisors LLC
Willett Advisors LLC investment in Series D - Finch Therapeutics
MSD Capital
MSD Capital investment in Series D - Finch Therapeutics
Octave Group
Octave Group investment in Series D - Finch Therapeutics
Susquehanna International Group (SIG)
Susquehanna International Group (SIG) investment in Series D - Finch Therapeutics
OMX Ventures
OMX Ventures investment in Series D - Finch Therapeutics
Octave Ventures LLC
Octave Ventures LLC investment in Series D - Finch Therapeutics
MSD Partners
MSD Partners investment in Series D - Finch Therapeutics
Avenir Growth Capital
Avenir Growth Capital investment in Series D - Finch Therapeutics
Humboldt Fund
Humboldt Fund investment in Series D - Finch Therapeutics
Key Employee Changes
Official Site Inspections
http://www.finchtherapeutics.com Semrush global rank: 225.66 K Semrush visits lastest month: 322.22 K
- Host name: 104.21.3.217
- IP address: 104.21.3.217
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Finch Therapeutics"
About — Finch Therapeutics
About us Our board of directors Key milestones in the field & Finch’s history 4th century First written accounts emerge from China of therapeutic applications …See details»
Finch Therapeutics - Crunchbase Company Profile
Finch Therapeutics is a microbiome development company that serve patients …See details»
Finch Therapeutics Group (FNCH) Company Profile & Description
Jul 30, 2025 Company profile for Finch Therapeutics Group, Inc. (FNCH) with a description, list of executives, contact details and other key facts.See details»
Clinical Trials — Finch Therapeutics
Our desire to transform lives drives our work We are dedicated to developing innovative microbiome therapeutics that have the potential to transform lives. To learn more about our …See details»
Portfolio — Finch Therapeutics
About our portfolio of microbiome assets The microbiome: Essential for health.Harnessed for medicine. The microbiome consists of trillions of microbes that live symbiotically in and on …See details»
Finch Therapeutics and Takeda Expand Collaboration to Develop ...
Nov 13, 2019 SOMERVILLE, Mass.– (BUSINESS WIRE)–Finch Therapeutics Group, Inc. (“Finch”) and Takeda Pharmaceutical Company Limited (“Takeda”; TSE:4502/NYSE:TAK) …See details»
Investor Relations — Finch Therapeutics
The Investor Relations website contains information about Finch Therapeutics's business for stockholders, potential investors, and financial analysts.See details»
Finch Therapeutics Announces $90 Million Financing to Advance …
Sep 17, 2020 Proceeds to support the advancement of lead candidate through the final stages of clinical development for recurrent C. difficile infection, and the advancement into the clinic of …See details»
Finch Therapeutics - LinkedIn
Finch Therapeutics | 9,782 followers on LinkedIn. Finch Therapeutics has a portfolio of microbiome assets including CP101, a late-stage, investigational, orally administered …See details»
Finch Therapeutics Provides Corporate Update and Reports First …
SOMERVILLE, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics …See details»
Jobs — Finch Therapeutics
Contact us [email protected] 617-229-6499 75 State Street Suite 100, Mailbox 5836 Boston MA, 02109 PoliciesSee details»
Finch Therapeutics Reports Fourth Quarter and Full Year 2022 …
SOMERVILLE, Mass., March 23, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology …See details»
Finch Therapeutics Announces Executive Leadership Transitions
SOMERVILLE, Mass., April 25, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology …See details»
Finch Therapeutics Group Raises $36 Million in Series B Financing
Mar 1, 2018 SOMERVILLE, Mass.– (BUSINESS WIRE)–Finch Therapeutics Group, Inc. (Finch), a privately held microbiome therapeutics company, announced today the successful close of …See details»
Finch Therapeutics Reports First Quarter 2021 Financial Results …
SOMERVILLE, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch” or the “Company”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics …See details»
Finch Therapeutics (USA) Funding: $188.8M - Medical Startups
Jul 7, 2025 Finch Therapeutics Group is a clinical-stage biopharmaceutical company focused on developing and delivering innovative therapies that harness the human gut...See details»
Finch Therapeutics - Company Profile & Staff Directory | ContactOut
Finch Therapeutics is a Biotechnology company located in 200 Inner Belt Road, Somerville, MA, 02143, US with 38 employees. Access Finch Therapeutics's email format and Finch …See details»
Policies — Finch Therapeutics
However, when you contact emails within the finchtherapeutics.com domain, we may collect personal information, such as your e-mail address, name, home or work address and/or …See details»
Finch Therapeutics Group, Inc. (FNCH) - Yahoo Finance
Find the latest Finch Therapeutics Group, Inc. (FNCH) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Finch Therapeutics Provides Corporate Updates and Reports Third …
Nov 10, 2022 Finch routinely posts information that may be important to its investors on its website at www.finchtherapeutics.com. Finch encourages investors to consult the “Investors & …See details»